Self-assembled polymeric vesicles: Focus on polymersomes in cancer treatment

F Araste, A Aliabadi, K Abnous, SM Taghdisi… - Journal of Controlled …, 2021 - Elsevier
The progress in advanced materials using nanoscale components can be conducted by an
innovative idea involving combining nanotechnology approaches with supramolecular …

The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery

MJ Saadh, H Baher, Y Li, JL Arias-Gonzáles… - Environmental …, 2023 - Elsevier
The multidisciplinary approaches in treatment of cancer appear to be essential in term of
bringing benefits of several disciplines and their coordination in tumor elimination. Because …

The impact of nanoparticles on the immune system: a gray zone of nanomedicine

P Ray, N Haideri, I Haque… - Journal of …, 2021 - immunologyresearchjournal.com
Since the early days marking the first use of nanomedicine in the early 80s, there has been a
meaningful change in the scientific field involving the Fabrication, characterization, and …

Synthesis and biological properties of coumarin derivatives. A review

A Bouhaoui, M Eddahmi, M Dib, M Khouili… - …, 2021 - Wiley Online Library
Coumarin and its derivatives are widely used as scaffolds in the synthesis of new
heterocyclic systems. This review focuses on current developments in the synthesis of …

Rational design of polymeric micelles for targeted therapeutic delivery

Y Zheng, Y Oz, Y Gu, N Ahamad, K Shariati… - Nano Today, 2024 - Elsevier
Polymeric micellar drug carriers have emerged as effective tools to enhance the solubility
and bioavailability of hydrophobic drugs. These micelles possess a nano size structure that …

Research progress on stimulus-responsive polymer nanocarriers for cancer treatment

S Luo, Z Lv, Q Yang, R Chang, J Wu - Pharmaceutics, 2023 - mdpi.com
As drug carriers for cancer treatment, stimulus-responsive polymer nanomaterials are a
major research focus. These nanocarriers respond to specific stimulus signals (eg, pH …

pH-sensitive nanodrug carriers for codelivery of ERK inhibitor and gemcitabine enhance the inhibition of tumor growth in pancreatic cancer

P Ray, D Dutta, I Haque, G Nair… - Molecular …, 2020 - ACS Publications
Pancreatic ductal adenocarcinoma (PDAC), a metabolic disorder, remains one of the
leading cancer mortality sources worldwide. An initial response to treatments, such as …

Regulation of tumor microenvironment for pancreatic cancer therapy

X Huang, L Ding, X Liu, R Tong, J Ding, Z Qian, L Cai… - Biomaterials, 2021 - Elsevier
Pancreatic cancer (PC) is one kind of the most lethal malignancies worldwide, owing to its
insidious symptoms, early metastases, and negative responses to current therapies. With an …

Polymeric micelles formulation of combretastatin derivatives with enhanced solubility, cytostatic activity and selectivity against cancer cells

ID Zlotnikov, AA Ezhov, AS Ferberg, SS Krylov… - Pharmaceutics, 2023 - mdpi.com
Combretastatin derivatives is a promising class of antitumor agents, tubulin assembly
inhibitors. However, due to poor solubility and insufficient selectivity to tumor cells, we …

Nanomedicine in pancreatic cancer: current status and future opportunities for overcoming therapy resistance

MK Greene, MC Johnston, CJ Scott - Cancers, 2021 - mdpi.com
Simple Summary Despite access to a vast arsenal of anticancer agents, many fail to realise
their full therapeutic potential in clinical practice. One key determinant of this is the evolution …